Journal articleEvid Based Complement Alternat Med2021
Retracted: Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1.
- Journal
- Evid Based Complement Alternat Med
- Published
- 20 February 2021
- Citations
- 0
- Type
- Article
- License
- cc by
- Full text
- Open access, reuse-licensed (cc by)
- Retracted
- Yes
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.
Try